These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18728358)

  • 21. A novel deletional beta-thalassemic variant in an ethnic Qatari patient.
    Al-Obaidli A; Gerard N; Al Zadjali S; Fawzi Z; Pravin S; Pathare A; Krishnamoorthy R
    Hemoglobin; 2009; 33(3):214-9. PubMed ID: 19657835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hb Niigata [beta1(NA1)Val-->Leu] in a Romanian individual resulting from another nucleotide substitution than that found in the Japanese.
    Moradkhani K; Henthorn J; Riou J; Phelan L; Préhu C; Wajcman H
    Hemoglobin; 2007; 31(4):477-82. PubMed ID: 17994382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein C and protein S deficiency in thalassemic patients.
    Shirahata A; Funahara Y; Opartkiattikul N; Fucharoen S; Laosombat V; Yamada K
    Southeast Asian J Trop Med Public Health; 1992; 23 Suppl 2():65-73. PubMed ID: 1298996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombotic complications in thalassemic patients: contribution of red blood cells and platelets.
    Shenkman B
    Thromb Haemost; 2008 Nov; 100(5):735. PubMed ID: 18989511
    [No Abstract]   [Full Text] [Related]  

  • 25. [Intermediate thalassemia: a new condition associated with hypercoagulability].
    Mannucci PM
    Ann Ital Med Int; 2000; 15(3):187-8. PubMed ID: 11059057
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemostatic alterations in splenectomized and non-splenectomized patients with beta-thalassemia/hemoglobin E disease.
    Tripatara A; Jetsrisuparb A; Teeratakulpisarn J; Kuaha K
    Thromb Res; 2007; 120(6):805-10. PubMed ID: 17382994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Ggamma(Agammadeltabeta)0 thalassemia in North India.
    Chakrabarti P; Dash D; Panda BK
    Clin Chim Acta; 2006 Feb; 364(1-2):363-4. PubMed ID: 16112101
    [No Abstract]   [Full Text] [Related]  

  • 28. Origin of the codon 47 (+A) beta-thalassaemia mutation among the Nicobarese of the Andaman and Nicobar islands in India.
    Gorakshakar AC; Das MK; Phanasgaokar SP; Nadkarni AH; Colah RB; Mohanty D
    Br J Haematol; 2007 Oct; 139(2):345-6. PubMed ID: 17897314
    [No Abstract]   [Full Text] [Related]  

  • 29. Hb Beograd [beta121(GH4)Glu-->Val, GAA-->GTA] in the Turkish population.
    Atalay A; Koyuncu H; Köseler A; Ozkan A; Atalay EO
    Hemoglobin; 2007; 31(4):491-3. PubMed ID: 17994384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalassemia intermedia in two patients with Hb Lepore-beta zero-thalassemia (Frameshift codon 8, -AA).
    Bozkurt G; Baysal E; Gu LH; Huisman TH
    Hemoglobin; 1994 May; 18(3):247-50. PubMed ID: 7928383
    [No Abstract]   [Full Text] [Related]  

  • 31. De novo HBB frameshift mutation in a patient with dominant β-thalassemia major.
    Zhou X; Chen T; Zhang Q; Qi M; Zhang L; Du J; Chi H; Shen B; Xu X; Lu Y
    Int J Lab Hematol; 2022 Feb; 44(1):e21-e25. PubMed ID: 34323379
    [No Abstract]   [Full Text] [Related]  

  • 32. A novel mutation of -50 (G-->A) in the direct repeat element of the beta-globin gene identified in a patient with severe beta-thalassemia.
    Li DZ; Liao C; Xie XM; Zhou JY
    Ann Hematol; 2009 Nov; 88(11):1149-50. PubMed ID: 19290524
    [No Abstract]   [Full Text] [Related]  

  • 33. [Non-enzymatic marking of gene probes using digoxigenin for the diagnosis of sickle cell mutation and beta thalassemia].
    Bürgi W; Keller E; Schmidheini T
    Schweiz Med Wochenschr; 1992 Oct; 122(42):1567-70. PubMed ID: 1411416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel frameshift mutation causing beta-thalassemia in a Sikh.
    el-Kalla S; Mathews AR
    Hemoglobin; 1995; 19(3-4):183-9. PubMed ID: 7558874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran.
    Taher A; Isma'eel H; Mehio G; Bignamini D; Kattamis A; Rachmilewitz EA; Cappellini MD
    Thromb Haemost; 2006 Oct; 96(4):488-91. PubMed ID: 17003927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombotic risk in thalassemic patients.
    Moratelli S; De Sanctis V; Gemmati D; Serino ML; Mari R; Gamberini MR; Scapoli GL
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():915-21. PubMed ID: 10091165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The haematological phenotype and genotype analysis on 14 co-inheritance of hemoglobin Constant Spring and β-thalassemia].
    Li YQ; Yang T; Ling XZ; Liang L
    Zhonghua Xue Ye Xue Za Zhi; 2013 Dec; 34(12):1067-9. PubMed ID: 24369169
    [No Abstract]   [Full Text] [Related]  

  • 38. Compound heterozygosity for Hb Tacoma [beta30(B12)Arg-->Ser] and beta+-thalassemia.
    Landin B; Alvelius G; Rai DK; Elinder G
    Hemoglobin; 2000 Aug; 24(3):253-7. PubMed ID: 10975446
    [No Abstract]   [Full Text] [Related]  

  • 39. Hb Lepore-Leiden: a new delta/beta rearrangement associated with a beta-thalassemia minor phenotype.
    Harteveld CL; Wijermans PW; Arkesteijn SG; Van Delft P; Kerkhoffs JL; Giordano PC
    Hemoglobin; 2008; 32(5):446-53. PubMed ID: 18932069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercoagulable state in five thalassemia intermedia patients.
    Bhattacharyya M; Kannan M; Chaudhry VP; Mahapatra M; Pati H; Saxena R
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):422-7. PubMed ID: 17911195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.